Stable Isotope Labeled Compounds

World Market Report

MCP15002

EXECUTIVE ENGAGEMENTS

POOL

692
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

138
Interactions with Platform & by Email

PARTICIPANTS

28
Unique # Participated

VALIDATIONS

11
Responses Validated*

COMPANIES

73
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2023

TABLES

157

PAGES

408

EDITION

9

PRICE

USD 5450

CODE

MCP15002


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2023?

» Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Stable Isotope Labeled Compounds Market to Reach $365.2 Million by 2027
In the changed post COVID-19 business landscape, the global market for Stable Isotope Labeled Compounds estimated at US$282.6 Million in the year 2020, is projected to reach a revised size of US$365.2 Million by 2027, growing at a CAGR of 3.7% over the analysis period 2020-2027. Deuterium, one of the segments analyzed in the report, is projected to record a 4.9% CAGR and reach US$149.6 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Oxygen-18 segment is readjusted to a revised 3.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $110.7 Million, While China is Forecast to Grow at 5.8% CAGR
The Stable Isotope Labeled Compounds market in the U.S. is estimated at US$110.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$27.2 Million by the year 2027 trailing a CAGR of 5.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.Carbon-13 Segment to Record 2.7% CAGR
In the global Carbon-13 segment, USA, Canada, Japan, China and Europe will drive the 2.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$43.3 Million in the year 2020 will reach a projected size of US$51.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

SELECT PLAYERS

3M Company; Alsachim; BOC Sciences; Cambridge Isotope Laboratories, Inc.; Chemtos; ISOFLEX; IsoSciences; Isotope JSC; Medical Isotopes, Inc.; Merck KGaA; Omicron Biochemicals, Inc.; Pepscan; PerkinElmer Inc. ; The State Atomic Energy Corporation ROSATOM; Trace Sciences International; Urenco Stable Isotopes

SEGMENTS

» Type (Deuterium, Oxygen-18, Carbon-13, Nitrogen-15, Other Types) » End-Use (Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers, Other End-Uses)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Middle East » Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Impact of COVID-19 Pandemic and Looming Global Recession
Year 2021 in Review and Near-term Outlook
Prolonged Pandemic, Ukraine-Russia Conflict and Ensuing Economic Disruptions Impact Growth Outlook
COVID-19 Creates Supply Chain Hiccups in the Medical Isotope Market
An Introduction to Stable Isotope Labeled Compounds
Advantages of Stable Isotope Labeling
Radioactive versus Stable Isotopes
Global Market Prospects & Outlook
Developed Regions Lead, Developing Economies to Fuel Long-term Growth
Competition
Stable Isotope Labeled Compounds – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for 41 Players Worldwide in 2022 (E)
World Brands
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Sustained Increase in Research Activities in Pharma and Biotech Sectors Augurs Well for the Market
EXHIBIT: Pharmaceutical R&D Spending Worldwide (USD Billion) for 2015-2025
EXHIBIT: R&D Spending as % of Revenues in Select Leading Pharmaceutical Companies (2021)
EXHIBIT: R&D Spending (in US$ Billion) of Select Leading Biotechnology Companies for 2020
Numerous Benefits of Stable Isotope Labelling in Biochemistry Research Propels Market Prospects
Focus on Proteomics Research Presents Growth Opportunities for Stable Isotope Labeled Compounds
EXHIBIT: Global Proteomics Market Revenues (in US$ Million) by Geographic Region/Country for 2020 and 2027
Proteomics Emerges as an Important Research Tool in Battle against COVID-19
Pressing Need for COVID-19 Diagnostics & Therapeutics Accentuates Dynamic Role of Proteomics
Gaining Insights into COVID-19 & Drug Discovery with Proteomics
Proteomics to Enable Potent Antiviral Agents & Better Vaccines against COVID-19
Rising Prevalence of Cancer Worldwide Drives Market Growth
EXHIBIT: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT: Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2020
EXHIBIT: Number of New Cancer Cases and Deaths (in Million) by Region for 2020
Rising Adoption of PET Scans for Disease Staging to Support Market Prospects
Role of Stable Isotopes in Nuclear Industry & Status of Nuclear Reactors Drives Demand for Stable Isotopes
EXHIBIT: Global Electricity Production Breakdown by Source
EXHIBIT: World Installed Nuclear Power Generation Capacity (in GW) for 2020, 2030, 2040 and 2050
Rising Importance of Stable Isotopes Human Nutritional Studies
Pharmacokinetic and Metabolic Fate of Drugs: Better Understood with Isotopic Labeling of Metabolites
Advancements in Deuterium-Labeled Compounds Synthesis
Research Study Investigates Metagenomes’ Genetic Capacity to Translate into Production of VOCs of Interest
Chemical Tagging Stable Isotope Products for Chemical Labeling
Stable Isotope Studies Aid in Integration of Non-essential Amino Acids in Pea Aphids
Using Stable Isotopes to Measure Denitrification Rates in Soil
Use of Stable Isotopically Labeled Benzene to Evaluate Environmental Exposures
Stable Isotope Assisted Technique (LC-MS–Based) Offers Better Metabolites Characterization: A Brief Review
Growing Role of Stable Isotopes in Animal Migration Research
Recent Labelling Advancements in Organic Molecules
Creation of Stable Isotope Labeled Internal Standards
Mass Spec Internal Standards: Comparing Different Isotopic Labels
Use of Stable Labeled Compounds in the form of Internal Standards
4. GLOBAL MARKET PERSPECTIVE
World Stable Isotope Labeled Compounds Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027
World Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Stable Isotope Labeled Compounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Stable Isotope Labeled Compounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Deuterium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Deuterium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Deuterium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Oxygen-18 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Oxygen-18 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Oxygen-18 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Carbon-13 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Carbon-13 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Carbon-13 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Nitrogen-15 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Nitrogen-15 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Nitrogen-15 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
UNITED STATES
Stable Isotope Labeled Compounds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
CANADA
Stable Isotope Labeled Compounds Market Presence - Strong/Active/Niche - Key Competitors in the Canada for 2022 (E)
Canada Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
JAPAN
Japan Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
CHINA
Stable Isotope Labeled Compounds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
EUROPE
Stable Isotope Labeled Compounds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Stable Isotope Labeled Compounds by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Stable Isotope Labeled Compounds by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
FRANCE
France Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
GERMANY
Germany Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
UNITED KINGDOM
UK Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
SPAIN
Spain Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
Spain Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
RUSSIA
Russia Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
Russia Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Stable Isotope Labeled Compounds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Stable Isotope Labeled Compounds by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Stable Isotope Labeled Compounds by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
AUSTRALIA
Australia Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
Australia Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
INDIA
India Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
India Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
SOUTH KOREA
South Korea Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
South Korea Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
LATIN AMERICA
Latin America Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
MIDDLE EAST
Middle East Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
AFRICA
Africa Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2012, 2021 & 2027
Africa Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com